Remdesivir Reduces COVID-19 Mortality Risk, Analysis Shows

Reuters (6/21, Roy) reports Gilead Sciences on Monday “said an analysis showed its antiviral remdesivir reduced mortality rates in hospitalized patients with COVID-19 and increased the likelihood of being discharged by day 28 after a five-day course of th...